Abstract Agonist-induced receptor phosphorylation plays a role in transmembrane signal transduction systems. Although the cDNA for the rat vascular type 1 angiotensin II receptor (AT 1A R) encodes a G protein-coupled receptor with several potential phosphorylation sites for serine/threonine and tyrosine kinases, little is known about the phosphorylation of this receptor. The aim of this study was to determine the effects of angiotensin II (Ang II) on phosphorylation of the AT !A R in rat aortic vascular smooth muscle cells. Using [-"PJorthophosphate-labeled cells, immunoprecipitates with anti-AT 1A R antibody revealed a labeled band of molecular weight 52 kD, corresponding to the Ang II receptor. Ang II induced a rapid and significant increase in phosphorylation of the Ang II receptor, with a peak at 20 minutes. Phosphoamino acid analysis showed that the major phosphoamino acid is serine, in both the basal and Ang II-stimulated states. Constitutive and A gonist-induced receptor phosphorylation has / \ been considered to play a pivotal role in trans-A. \ . membrane signal transduction systems by regulating receptor function and distribution. Previous studies have demonstrated that phosphorylation of G protein-coupled receptors, including a-and /3-adrenergic receptors (ARs), rhodopsin receptors, and muscarinic cholinergic receptors (mChRs), induces receptor desensitization by reducing the affinity for binding agonist ligands and/or reducing the ability to interact with biochemical effectors.
A gonist-induced receptor phosphorylation has / \ been considered to play a pivotal role in trans-A. \ . membrane signal transduction systems by regulating receptor function and distribution. Previous studies have demonstrated that phosphorylation of G protein-coupled receptors, including a-and /3-adrenergic receptors (ARs), rhodopsin receptors, and muscarinic cholinergic receptors (mChRs), induces receptor desensitization by reducing the affinity for binding agonist ligands and/or reducing the ability to interact with biochemical effectors. 14 This modulation of function has been shown to be associated with phosphorylation of serine and/or threonine residues of the receptor proteins via cyclic AMP-dependent protein kinase (PKA) and agonist-specific receptor kinases (G protein-coupled receptor kinases [GRKs] ) such as /3-AR kinase (0ARK) and rhodopsin kinase. 56 Studies on agonist-induced phosphorylation of /3-AR suggest that PKA plays a major role in heterologous desensitization at low agonist concentrations, whereas 0ARK is important in eliciting homologous desensitization at higher agonist concentrations. 7 In all instances, phosphorylation of serine and/or threonine residues of the receptor proteins appears to attenuate receptor function. 5 In contrast, the tyrosine kinase receptors appear to be susceptible to positive modulation by phosphoryla-agonist-stimulated tyrosine phosphorylation is also observed to a lesser extent. Immunoblotting of anti-phosphotyrosine immunoprecipitates with anti-AT 1A R antibody showed that Ang II caused a delayed tyrosine phosphorylation of the receptor with a peak at 20 minutes in a dose-dependent manner. Forskolin increased total phosphorylation of AT 1A R but had no effect on tyrosine phosphorylation. Neither phorbol 12-myristate-13-acetate nor ionomycin altered receptor phosphorylation. These findings suggest that Ang II induces the phosphorylation of its own G protein-coupled receptor through both serine and tyrosine kinases and raise the possibility that phosphorylation of the AT 1A R is an important regulator of receptor tion. With these receptors, autophosphorylation of tyrosine residues may lead to enhanced tyrosine kinase activity of the receptors and increased receptor function. 8 In receptors with intrinsic tyrosine kinases -such as those for insulin, insulin-like growth factor-1, and epidermal growth factor -and in so-called type 2 receptors (including those for low-density lipoprotein and transferring a specific motif containing a tyrosine residue is proposed to promote receptor internalization. 9 Recently, serine and/or threonine phosphorylation has been suggested to be involved in mChR internalization as well. 10 We have cloned the cDNA for the rat vascular type 1 angiotensin II receptor (AT, A R), a member of the G protein-coupled receptor superfamily. 11 The cDNA for the AT, A R encodes a protein with several potential phosphorylation sites for serine/threonine and tyrosine kinases, raising the possibility that phosphorylation of the AT 1A R might play an important role in regulating receptor function. Furthermore, we have previously shown that phenylarsine oxide, a tyrosine phosphatase inhibitor, inhibits AT 1A R internalization in cultured rat aortic smooth muscle (RASM) cells, 12 suggesting the possible involvement of tyrosine phosphorylation in the regulation of AT 1A R processing. With the development of antibodies to the AT 1A R, it has become possible to test these hypotheses directly.
We designed this study to determine whether angiotensin II (Ang II) induces phosphorylation of its own receptors in intact RASM cells and if so to identify the amino acids phosphorylated by Ang II. Our results indicate that the AT 1A R is a phosphoprotein in unstimulated RASM cells and that phosphorylation of the ATIAR is significantly increased on Ang II stimulation.
The AT 1A R is phosphorylated on both serine and tyrosine residues, suggesting a dual level of control.
Methods Materials
Ang II, forskolin, phorbol 12-myristate-13-acetate (PMA), and ionomycin were purchased from Sigma Chemical Co. Losartan was a gift from Dr R.D. Smith (Du Pont de Nemours Co). 
Culture of RASM Cells
Primary cultures of RASM cells were obtained by enzymatic dissociation of aortic medial tissue from male Sprague-Dawley rats, as described elsewhere. 13 Cells were passaged in Dulbecco's modified Eagle's medium (Hazelton) containing 10% calf serum (GIBCO Laboratories), as previously described. 13 For experiments, RASM cells from passages 5 through 15 were seeded on 100-mm dishes and fed every other day. On reaching confluence, RASM cells were incubated in serumfree medium for 48 hours before all experiments.
Preparation of Cell Lysate and Immunoprecipitation
RASM cells were washed three times with BSS (37°C). For phosphorylation analysis, cells were labeled with 400 jiCi/mL of [ 32 P]orthophosphate in BSS at 37°C for 6 hours. Ang II, forskolin, PMA, ionomycin, and losartan were added to the BSS for the final period of the incubation as indicated. The reaction was terminated by aspirating the buffer and washing with ice-cold PBS on ice. The cells were then lysed in ice-cold lysis buffer containing (mmol/L) HEPES 50 (pH 7.5) and phenylmethylsulfonyl fluoride 1, as well as 1% Triton X-100, NaCl 50, NaF 50, sodium pyrophosphate 10, EDTA 5, Na 3 VO 4 1,10 ^tg/mL aprotinin, and 10 £ig/mL leupeptin. Equal protein aliquots of the lysate (1 mg protein) were subjected to immunoprecipitation. Immunoprecipitation was performed according to the method of Molloy et al 14 using 1 Aig/mg protein of polyclonal anti-AT 1A R antibody against the peptide corresponding to amino acids 15 through 24 of the rat AT 1A R (anti-AT, prepared as described in detail previously in Reference 15) or 2 /xg/mg protein of monoclonal anti-PY. In some experiments, antibody against peptide corresponding to amino acids 183 through 190 (anti-Ang2.183) or amino acids 230 through 237 (anti-Ang2.230) 15 was used to verify the identity of the immunoreactive band. Immunoprecipitates were collected with protein A-Sepharose (Pharmacia) and subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Phosphorylation Analysis
After SDS-PAGE, anti-AT immunoprecipitates were transferred to Immobilon-P (Millipore Corp), and the membrane was subjected to autoradiography. For determination of the specific radioactive band that corresponded to the AT 1A R, the membrane was immunoblotted with anti-AT, and immunoreactive bands were visualized with a phosphatase detection system (Kirkegaard & Perry Laboratories). The immunoreactive bands were excised from the membrane, and the radioactivity of the bands was quantified by liquid scintillation spectroscopy.
Phosphoamino Acid Analysis
The radioactive bands corresponding to the AT 1A R were excised from the blotted membrane as described above and subjected to hydrolysis with 5.7N HC1 at 110°C for 1 hour. After lyophilization, the hydrolysate was spotted onto a thinlayer cellulose plate (JT Baker Inc) and subjected to onedimensional electrophoresis at 600 V for 1.5 hours in acetic acid/pyridine/water (50:5:945, pH 3.5). Radiolabeled phosphoamino acids were identified by autoradiography and comparison with unlabeled standards revealed with ninhydrin.
Immunoblotting for Tyrosine Phosphorylation
Lysates of nonlabeled RASM cells were immunoprecipitated with anti-PY as described above. Phosphotyrosine-containing proteins were subjected to 10% SDS-PAGE and transferred to Immobilon-P. Immunoreactive bands for anti-AT were visualized as described above. The relative changes in the content of phosphotyrosine-containing AT 1A R were quantified by scanning the immunoreactive bands using laser densitometry.
Statistical Analysis
Data are expressed as mean±SEM. ANOVA followed by a multiple comparison test was used for comparisons on initial data before expression as percentage of control. A value of P<.05 was considered statistically significant.
Results
Immunoprecipitation of RASM cells with anti-AT identified a single band of molecular weight 52 kD on immunoblotting with anti-AT (Fig 1A) . The identity of the 52-kD band as the AT 1A R was confirmed in several ways. First, anti-AT immunoreactive 52-kD bands were specifically blocked by incubation with an excess concentration of the immunizing peptide used in producing the anti-AT (Fig 1A) . Second, similar bands were observed when immunoblotting was performed using two other anti-ATi A R antibodies made independently against amino acids in the third extracellular domains (anti-Ang2.183) or against those in the third intracellular loop (anti-Ang2.230) of the AT 1A R. Furthermore, incubation with the peptide used in producing each of these antibodies also blocked the immunoreactive 52-kD band (Fig IB) . These findings demonstrate that the anti-AT immunoreactive 52-kD band is specific for the AT 1A R. To determine whether the AT 1A R is phosphorylated in intact cells, we incubated RASM cells with [^Jortho-phosphate and isolated the AT IA R by immunoprecipitation with anti-AT. In the basal state, immunoprecipitates contained a labeled band of molecular weight 52 kD, corresponding to the AT 1A R as indicated by immunoblotting with anti-AT (Fig 1C) . The phosphorylation of the band was significantly increased by stimulation with 100 nmol/L Ang II. Immunoprecipitation with anti-AT also brought down labeled proteins of 61, 73, 89, and 110 kD. However, none of these bands reacted with anti-AT on immunoblotting. As shown in Fig 2A, Ang II induced a rapid (within 1 minute) and significant increase in AT 1A R phosphorylation, with a peak at 20 minutes (226±28% of control, F<.01, n=5). The increase in phosphorylation was sustained for at least 4 hours. The Ang II-induced phosphorylation of the AT 1A R was completely inhibited by pretreatment (15 minutes) with 1 /xmol/L losartan, a specific AT 1A R antagonist (losartan, 98±13%; losartan+Ang II, 108±17% of control; n=4), indicating that the receptor phosphorylation is mediated by an Ang II-AT 1A R interaction. We performed phosphoamino acid analysis to determine the characteristics of the basal and Ang IIinduced phosphorylation of the AT 1A R (Fig 3) . In the basal state, the major phosphoamino acid was serine, with a small amount of phosphate found in tyrosine residues. After 20 minutes of Ang II, both serine and tyrosine phosphorylation were increased. Phosphothreonine was not evident in either state.
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Subsequent analysis of Ang II-induced tyrosine phosphorylation of the AT [A R was performed using anti-PY immunoprecipitation, followed by immunoblotting with anti-AT. Phosphotyrosine-containing AT 1A R was detected in the basal state but was not significantly increased until 10 minutes after stimulation of Ang II and peaked at 20 minutes (163±17%, /><.01, n=5) (Figs ID and 2B). The tyrosine phosphorylation declined within 60 minutes to a new level, which remained slightly elevated over basal levels for at least 4 hours. Losartan completely inhibited the Ang II-dependent tyrosine phosphorylation of the AT U R (losartan, 103 ±11%; losartan+Ang II, 106±12%; n=4). The AT 1A R tyrosine phosphorylation was dose dependent, with a threshold of 0.1 nmol/L (122±18% of control, n=3), an EQo of 4.0 ±2.0 nmol/L (n=3), and a maximal effect at 100 nmol/L Ang II (178±29%, n=3).
To determine whether the ubiquitous protein kinases PKA, protein kinase C (PKC), or Ca 2+ -dependent protein kinases were able to induce AT 1A R phosphorylation, we used the PKA activator forskolin, the PKC activator PMA, and the Ca 2+ ionophore ionomycin. As shown in Fig 4, forskolin (10 /xmol/L for 15 minutes) increased the total phosphorylation of the AT 1A R to 230±49% (P<.01, n=3), with no effect on tyrosine phosphorylation. Neither PMA (100 nmol/L for 20 minutes) nor ionomycin (2 ^.mol/L for 2 minutes) had any effect on total or tyrosine phosphorylation of the AT 1A R.
Discussion
In the present study we demonstrate that the AT^R is phosphorylated not only constitutively but also in an agonist-dependent manner in intact RASM cells. The AT 1A R also appears to be phosphorylated by PKA but not PKC. Serine residues are the major phosphoamino acids in both the basal and Ang H-stimulated states, with a smaller but significant content of phosphotyrosine residues. The ability of Ang II to induce phosphorylation of its receptor on both serine and tyrosine has not yet been reported among members of the G protein-coupled receptor superfamily and suggests regulation by multiple kinases. The 52-kD band was consistently detected as a single immunoreactive band on immunoprecipitation followed by immunoblotting, using any of three independent antibodies for the AT 1A R against the different portions of the AT 1A R molecules (anti-AT, anti-Ang2.183, and anti-Ang2.230). Furthermore, the peptide competition tests with each immunizing peptide snowed the specific inhibition of the immunoreactive band for each antibody. These findings demonstrate that the immunoreactive 52-kD band is specific for the AT 1A R. The band most likely represents a glycosylated form of the AT 1A R. The calculated molecular weight of the deduced, nonglycosylated AT 1A R is 41 kD.
11 Anti-AT identifies a 43-kD band when a nonglycosylated form of the AT 1A R is synthesized in vitro using a rabbit reticulocyte lysate system. 15 However, in several other rat tissues, immunoblotting with anti-AT identifies a 49-kD band. 15 These differences in the apparent molecular weight of the AT 1A R are most likely due to variations in glycosylation, because there are three potential glycosylation sites in the AT 1A R molecules and because previous studies have pointed out differences in the carbohydrate content of the receptors depending on species and tissues. 17 Presently, the pathway by which Ang II leads to phosphorylation of its own receptor is not known. Since the AT 1A R couples to both phospholipases C and D in RASM cells, 13 ' 18 the kinase involved in the agonistdependent phosphorylation of the AT 1A R might be either a Ca -dependent protein kinase or PKC. Neither ionomycin nor PMA, however, induced AT^R phosphorylation. Alternatively, an agonist-specific receptor kinase, such as /3ARK, may mediate Ang IIinduced AT 1A R phosphorylation. In support of this possibility, no second messenger appears to be involved in the agonist-dependent phosphorylation by /3ARK or rhodopsin kinase, 6 a result in agreement with our ionomycin and PMA experiments. Furthermore, the phosphorylation catalyzed by 0ARK and rhodopsin kinase has been proposed to occur in the serine/threonine-rich C-terminal tail of the respective receptor.
2
- 5 The AT 1A R has several serine/threonine-rich domains in the C-terminal tail, and serine residues appear to be the major site phosphorylated by Ang II. Thus, it seems likely that a member of the GRK family may be involved in agonist-dependent phosphorylation of the AT 1A R. The kinase responsible for the basal phosphorylation of the AT 1A R may be different, because most GRKs isolated to date require agonist stimulation for activation of the phosphorylation effect. Recent evidence suggests that Ang II induces tyrosine phosphorylation of several proteins in RASM cells.
-
19 Although these findings imply that Ang II activates tyrosine kinases and/or inhibits tyrosine phosphatases, the precise pathways involved are unknown. The delay in onset of AT M R tyrosine phosphorylation on Ang II stimulation as compared with that for total phosphorylation suggests that activation of a complex protein kinase cascade may be required for tyrosine phosphorylation of the AT^R. The inability of PMA and ionomycin to increase AT 1A R tyrosine phosphorylation suggests that this cascade does not include PKC or Ca 2+ -dependent protein kinases.
The observation that forskolin increased the total phosphorylation of AT 1A R is not unexpected, because there is a potential consensus sequence for PKAmediated phosphorylation in the C-terminal tail of the AT M R.
n However, PKA is not normally activated on AT^R stimulation in RASM cells, 20 suggesting that this kinase is likely to be involved in heterologous rather than homologous receptor regulation. Indeed, in y3-ARs, serine phosphorylation mediated by PKA is postulated to play a role in heterologous desensitization of receptors. 7 In particular, a recent study has shown that activation of /3-ARs leads to heterologous desensitization, internalization, and downregulation of ml mChRs via phosphorylation on serine. 21 Thus, the PKA-mediated phosphorylation of the AT 1A R may indicate that this receptor is also susceptible to heterologous regulation by PKA-coupled receptors, suggesting a possible interaction between vasoconstrictors such as Ang II and vasodilators such as 0-adrenergic agonists.
It is plausible that agonist-induced phosphorylation of the AT [A R may play a role in the regulation of receptor function. Rapid desensitization of G proteincoupled receptors has been shown to be caused by intrinsic changes in the receptors that decrease the effectiveness with which they can activate G proteins and effectors. 56 Specifically, GRKs and PKA control the efficacy of receptor coupling to G proteins by rapidly phosphorylating the receptor at serine/threonine residues. 2^-7 By analogy, it is likely that Ang II-induced phosphorylation of the AT, A R may function in homologous desensitization. Alternatively, receptor phosphorylation may be involved in the regulation of receptor processing. We have previously shown that Ang IIinduced internalization of the AT 1A R can be prevented by phenylarsine oxide, a tyrosine phosphatase inhibitor. 12 In so-called type II receptors (acceptors) and receptor tyrosine kinases, a tyrosine-containing motif has been proposed to play a crucial role in internalization of the receptors. 9 This motif, NPXY, does, in a slightly modified version (NPXXY), occur in the AT^R. Taken together, these observations raise the possibility that phosphorylation of the AT, A R on tyrosine may be involved in the regulation of receptor processing, including internalization, recycling, or resensitization of the receptors.
The present study suggests that Ang II induces phosphorylation of its own receptors through modulation of not only serine/threonine but also tyrosine kinases. Future studies will be designed to clarify the precise mechanisms responsible for serine and tyrosine phosphorylation of the AT 1A R and to determine the physiological consequences of AT^R phosphorylation.
